Madrigal Pharmaceuticals Inc (MDGL) is a Healthcare · Biotechnology company listed on NASDAQ. Price $535.63 (+0.23%), Market cap $12.11B, 52-week low–high $267.56 ~ $602.83.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Financial statements, price targets, institutional (13F) holdings and related news for Madrigal Pharmaceuticals Inc are updated in real time on BlackAll Trade.
Madrigal Pharmaceuticals Inc trades at $535.63 (+0.23%). Real-time quotes and charts are available on BlackAll Trade.
Madrigal Pharmaceuticals Inc has a market cap of about $12.11B.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdif